SEC Form 4 · accession 0000874015-17-000063
IONIS PHARMACEUTICALS INC · IONS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
B Lynne Parshall
Officer — COO · Director
Period of report
Oct 18, 2017
Accepted (ET)
Oct 20, 2017 · 5:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 18, 2017 | M | 7,785 | $14.69 | A | 33,526 | D | |
| Common StockF1 | Oct 18, 2017 | S | 7,785 | $65.00 | D | 25,741 | D | |
| Common StockF1 | Oct 18, 2017 | M | 8,333 | $39.87 | A | 34,074 | D | |
| Common StockF1 | Oct 18, 2017 | S | 8,333 | $65.00 | D | 25,741 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $14.69 | Oct 18, 2017 | M | 7,785 | D | Jan 2, 2017 | Jan 29, 2020 | Common Stock | 7,785 | 0 | D |
| Employee Stock Option (right to buy)F2 | $39.87 | Oct 18, 2017 | M | 8,333 | D | Jan 2, 2015 | Jan 1, 2021 | Common Stock | 8,333 | 74,167 | D |
Explanation of responses
- F1Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on 8/8/2017.
- F2Grant of 1/2/2014 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan. 25% of the shares subject to the option vest and become exercisable on 1/2/2015. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 20,625 shares per year. Following this transaction, the option was exercisable as to 69,010 on 10/18/2017.